Fig. 4From: Emodin-loaded polymer-lipid hybrid nanoparticles enhance the sensitivity of breast cancer to doxorubicin by inhibiting epithelial–mesenchymal transitionThe characterization of E-PLNs. A The morphology of E-PLNs. B Lyophilized powder of E-PLNs. C, D The particle size and Zeta potential of E-PLNs was measured by the laser particle size analyzerBack to article page